CHK1 inhibition sensitizes pancreatic cancer cells to gemcitabine via promoting CDK-dependent DNA damage and ribonucleotide reductase downregulation

Min Liang(Guangzhou Medical University), Yingjie Guo(Jilin University)
Oncology Reports
December 20, 2017
Cited by 20


Related Papers